Emerging infectious diseases are those that have undergone one or more significant changes:
Geographic range expansion.
Host species transfer.
Increased severity or impact.
Changes in pathogenesis (the mechanisms of infection).
Caused by newly evolved pathogens.
Example: COVID-19 and other zoonotic diseases (transmitted from animals to humans).
Zoonotic diseases impact wildlife populations and could increase disease spread.
75% of emerging infectious diseases in humans are transmitted from animals.
Examples include COVID-19, bubonic plague, HIV, influenza, SARS, Ebola, rabies, Lyme disease, West Nile virus.
Diseases such as COVID-19 are caused by pathogens that jump from animals to humans.
Critique of bats as 'villains' in the spread of zoonotic diseases, especially during the COVID-19 pandemic.
Research focused on whether animals like bats are more likely to spread disease due to their diversity:
Bats account for about 20% of mammal species with over 1,400 species.
They are closely followed by rodents in diversity.
Study findings:
Rodents, bats, and primates contain the highest number of zoonotic diseases recorded.
Adjusting for species diversity shows a more even contribution of diseases across animal groups, including songbirds.
Chytridiomycosis: a fungal disease affecting amphibians (frogs, toads, salamanders, caecilians).
Oldest tetrapods, with a long history dating back over 350 million years.
Notable for permeable skin which facilitates breathing and absorption, yet increases susceptibility to diseases.
Approximately 6,600 amphibian species globally; about 30% are threatened, higher than most vertebrate groups.
Approximately 700 species of amphibians are infected, causing population declines in 200 species, extinction in at least three species:
Panamanian golden frog: Extinct in the wild, but held in captivity.
Sharp snouted frog: Last seen in 1997 and may be extinct.
Australian gastric brooding frog: Famous for its unique reproductive method; extinct in the wild.
Caused by a pathogenic chytrid fungus (BD fungus), it infects the skin, disrupting electrolyte balance and leading to cardiac arrest.
Its motile larvae can swim and easily infect other amphibians.
Likely spread related to the global amphibian trade and pet ownership, with historical evidence dating back to 1938.
Factors contributing to spread:
High-density breeding in pools.
Metamorphosis period leads to immune suppression.
Laboratory cures exist, but effective environmental treatments are lacking.
Probiotic treatments show promise for individual-based cures.
Genetic diversity among amphibians may provide resistance.
White nose syndrome (WNS) affects bats and has led to the death of over 6 million bats in North America.
Fungus (Pseudogymnoascus destructans) thrives in cold hibernacula, causing excessive waking and energy depletion in bats during hibernation.
Species affected demonstrates significant population declines (e.g., little brown bat, Myotis lucifugus).
The fungus is host generalist and can survive without a host. It is not harmful to European bats, indicating specifics of American bat populations and ecology are at play.
Prevention strategies must focus on controlling human movement between caves and educating the public on the disease’s impact.
Techniques under investigation include:
Temperature regulation of caves to affect fungal growth.
Biological control using antifungal bacteria.
Efforts to genetically rescue bat populations for disease resistance.
Understanding and combating emerging infectious diseases, such as chytridiomycosis and white nose syndrome, requires interdisciplinary approaches, including wildlife conservation, virology, and ecology.